Advanced in Mitochondrial Complex 2 Deficiency

Anthony J. Gill

Royal North Shore Hospital, 
St Leonards, NSW, AU 
Advanced in Mitochondrial Complex 2 Deficiency
Royal North Shore Hospital, 
St Leonards, NSW, AU 
OverviewLocationsClinical Research

Overview

Anthony Gill practices in St Leonards, Australia. Mr. Gill is rated as an Advanced expert by MediFind in the treatment of Mitochondrial Complex 2 Deficiency. His top areas of expertise are Pancreatic Cancer, Neuroendocrine Tumor, Parathyroid Adenoma, Pancreaticoduodenectomy, and Pancreatectomy.

His clinical research consists of co-authoring 550 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Mitochondrial Complex 2 Deficiency.

Gender
Male

Locations

Royal North Shore Hospital, St Leonards, NSW, Australia
Other Locations
Royal North Shore Hospital, Sydney, NSW, Australia
Camperdown, NSW, Australia
Royal North Shore Hospital, St. Leonards
North Shore, NSW, Australia
Darlinghurst, NSW 2010, Australia
NSW 2064, Australia
Douglass Hanly Moir Pathology
Macquarie Park, NSW 2113, Australia
Central Coast, NSW, Australia
Newcastle, NSW, Australia
East Melbourne, VIC 3002, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Predicting RadIotherapy ReSponse of Rectal Cancer With MRI and PET
Predicting RadIotherapy ReSponse of Rectal Cancer With MRI and PET
Enrollment Status: Completed
Publish Date: October 28, 2022
Intervention Type: Other
Study Phase: Not Applicable

548 Total Publications

Correction to: Succinate dehydrogenase defcient renal cell carcinoma frequently expresses GATA3 and L1CAM.
Correction to: Succinate dehydrogenase defcient renal cell carcinoma frequently expresses GATA3 and L1CAM.
Journal: Virchows Archiv : an international journal of pathology
Published: July 25, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Gill's expertise for a condition
ConditionClose
View All 11 Distinguished Conditions
View All 27 Advanced Conditions
View All 90 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile